Back to Results
First PageMeta Content
Vaccines / Biology / Health / Cervarix / Ventricular septal defect / AS04 / Human papillomavirus / VSD / Teratology / Papillomavirus / Medicine / Congenital heart disease


Preclinical Developmental Toxicity Study Reports - Cervarix, June 9, 2009
Add to Reading List

Open Document

File Size: 1,08 MB

Share Result on Facebook

Company

GlaxoSmithKline / Glaxosmithkline plc / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

Food consumption / stainless steel cages / control / /

MedicalCondition

pulmonary trunk / HPV / congenital heart defect / small membranous intraventricular septal defect / ventricular septal defect / ventricular septal defects / pulmonary stenosis / prophylactic human papilloma virus type / membranous ventricular septal defect / infection / right ventricular hypertrophy / Tetralogy of Fallot / membranous intraventricular septal defects / Human Papillomavirus infections / syndrome / /

MedicalTreatment

immunization / /

Organization

Teratology Society / EC commission / Intramuscular Administration / FDA / Cervarix administration / VSD / OECD / /

Person

Marion F. Gruber / Monophosphoryl Lipid / M.P. Dent / Alum Lipid / Vaccine Adjuvanted / /

Position

Supervisor / Study director / Candidate / /

Product

IM injection / Virus Like Particle Vaccine / /

URL

http /

SocialTag